NCT00186667View on ClinicalTrials.gov

Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

January 31, 2000

Study Completion Date

September 30, 2005

Conditions
Graft vs Host DiseaseBlood and Marrow Transplant (BMT)
Interventions
PROCEDURE

high dose chemotherapy and autologous hematopoietic cell transplant

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00186667 - Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease | Biotech Hunter | Biotech Hunter